45
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Direct Pituitary Effects of Estrogen and Progesterone on Gonadotropin Secretion in the Ovariectomized Ewe

      research-article
      a , b
      Neuroendocrinology
      S. Karger AG
      Gonadotropin, Estrogen, Progesterone, Pituitary

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The direct pituitary effects of estrogen and progesterone on the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) were studied in ovariectomized (OVX) ewes in which the pituitary had been disconnected surgically from the hypothalamus (hypothalamo-pituitary disconnection, HPD). Gonadotropin secretion was restored with hourly pulses of 500 ng gonadotropin-releasing hormone (GnRH) via intra-atrial cannulae. Intramuscular injections of 50 µg estradiol benzoate (EB) to 5 sheep initially caused reductions (∼5O%) in plasma LH baseline, peak values and LH pulse amplitude. Therafter all parameters of plasma LH concentration increased 2- to 3-fold above starting values. After these 5 sheep had received 2 subcutaneous progesterone implants (mean ± SEM plasma levels 5.3 ± 1.5 nmol/1), the biphasic LH response to EB was still apparent and increases in LH peak values (267 ± 19%) and LH pulse amplitudes (262 ± 23%) were greater (p < 0.05) than those seen with EB alone (195 ± 11 and 172 ± 14%, respectively). The presence of 2 progesterone implants alone did not change plasma LH baseline, peak values or pulse amplitude, or plasma FSH values. In the second experiment, where 4 OVX-HPD ewes were given 4 progesterone implants (plasma progesterone 27.7 ± 3.4 nmol/l), there were no effects on basal plasma LH or plasma FSH values. The LH responses to EB were more marked in 4 OVX-HPD ewes given 4 progesterone implants than in the animals given EB alone. Also, the estrogen-induced LH surge occurred earlier in the ewes given 4 progesterone implants than in those given estrogen alone. The addition of 2 or 4 subcutaneous progesterone implants did not affect estrogen-induced suppression of FSH secretion in GnRH-pulsed OVX-HPD ewes. These data indicate that estrogen has a direct pituitary effect to influence the action of GnRH and that progesterone alone does not influence the secretion of LH or FSH by a direct pituitary effect. Progesterone may enhance the feedback effects of estrogen on LH secretion by a direct action at the pituitary level.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1984
          1984
          28 March 2008
          : 39
          : 3
          : 267-274
          Affiliations
          aMedical Research Centre, Prince Henry’s Hospital, and bDepartment of Neurosurgery, St Vincent’s Hospital, Melbourne, Australia
          Article
          123990 Neuroendocrinology 1984;39:267–274
          10.1159/000123990
          6438545
          42862c54-3c73-4925-abd4-5d954c7b9aec
          © 1984 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 10 November 1983
          : 05 March 1984
          Page count
          Pages: 8
          Categories
          Original Paper

          Endocrinology & Diabetes,Neurology,Nutrition & Dietetics,Sexual medicine,Internal medicine,Pharmacology & Pharmaceutical medicine
          Progesterone,Estrogen,Gonadotropin,Pituitary

          Comments

          Comment on this article